In the absence of any demonstrable T- 
IFN-a/o or IFN-13 alone interfered with the ability of poly(I. C) to impair the candidacidal activity of macrophages from SCID mice in vitro. These data suggest that poly(I-C)-induced interferons can impair the candidacidal activity of macrophages in SCID mice and decrease their innate resistance to acute systemic candidiasis and to systemic candidiasis of endogenous orngin.
Candida albicans is a member of the normal intestinal flora of most humans and animals (35) . Systemic spread of C. albicans from the intestine to the internal organs is a significant clinical problem for immunosuppressed individuals, such as cancer patients undergoing chemotherapy (16, 33) , and in individuals with congenitally impaired phagocytic cell function (14) . Iatrogenic or congenital immunosuppression and AIDS can also result in infection of cutaneous and mucosal surfaces by C. albicans (e.g., thrush and vaginitis) (20, 27) .
A number of strains of congenitally immunodeficient mice that are defective in innate and/or cell-mediated immune functions have been used in studies on resistance to candidiasis (4, 5, 7, 9, 11, 12, 15, 28, 41) . Studies on innate and acquired resistance of congenitally immunodeficient mice to candidiasis can help to define the immune cells that confer host resistance to systemic and/or mucosal candidiasis and provide much-needed models for in vivo studies of the immunomodulatory effects of cytokines on systemic and mucosal candidiasis. CB-17 mice with severe combined immunodeficiency (SCID) do not have demonstrable T-or B-cell responses (7), yet they are relatively resistant to acute systemic (intravenous [i.v.] challenge) candidiasis and systemic candidiasis of endogenous origin (29, 34) . The resistance of SCID mice to candidiasis suggests an important role for innate immunity in resistance to candidiasis. Recently, Cantorna and Balish demonstrated that systemic candidiasis of endogenous origin occurs in doubly immunodeficient bg/bg nu/nu mice but not in their congenic bg/bg nul+ counterparts (10) , suggesting a role for both T cells and phagocytic cells in host resistance to systemic candidiasis of endogenous origin. The roles of different phagocytic cells (macrophages [M+] and polymorphonuclear leukocytes [PMN] ) and the immunomodulatory role of cytokines in host * Corresponding author.
resistance to acute systemic candidiasis and systemic candidiasis of endogenous origin, however, have not been delineated.
Various in vitro studies suggest that the candidacidal activity of resident (8) and exudate (36) murine M4o is augmented by gamma interferon (IFN--y). IFN--y has also been shown to enhance the in vitro candidacidal activity of human PMN (17) but not of resident murine PMN (32) . In contrast, a recent in vivo study (23) suggests that IFN--y enhances murine susceptibility to i.v. challenge with Candida cells in immunologically naive mice but enhances resistance in C. albicans-immune mice. Poly(I. C) is a potent inducer of IFNs in vivo (21, 22) . In mice, poly(I -C) enhances production of IFN--y by natural killer (NK) cells (18) and of IFN-a and IFN-p by M4 (21, 22, 25, 30) . In mice, the primary effect of poly(I. C) appears to be the induction of IFN-, by M4 (21, 22, 25, 30) . In vitro, poly(I-C) induces production of IFN-1 by murine M, (38) , of IFN-a by human monocytes (43) , and of IFN-, by human fibroblasts (39) . In this study, we used CB-17 SCID mice to examine the immunomodulatory effects of poly(I-C)-induced IFNs on innate immunity to acute systemic candidiasis and systemic candidiasis of endogenous origin and on the candidacidal activity of phagocytic cells.
MATERIALS AND METHODS
Microorganisms. C. albicans B311 (type A) was maintained by monthly transfers on Sabouraud dextrose agar (SDA) slants. For experiments, C. albicans was grown on SDA slants for 24 h at 37°C. C. albicans was washed from the slant with sterile phosphate-buffered saline (PBS, pH 7.0), centrifuged (300 x g for 5 min), and resuspended in PBS at 105 CFU/ml.
Mice. Congenitally immunodeficient SCID CB-17 mice, NIH C57BL/6 (bgl+) mice, and N:NIH(S) III beige athymic (bg/bg nu/nu) mice were bred and housed in flexible film isolators at the University of Wisconsin Gnotobiotic Research Laboratory (Madison, Wis.). The germfree (GF) and flora-defined statuses of mice were assessed as described previously (6, 10) . SCID mice were determined to be immunodeficient by the absence of detectable immunoglobulin levels in serum (detection of less than 50 ,ug of immunoglobulin G [IgG], IgA, or IgM per ml by enzyme-linked immunosorbent assay [ELISA] [7] ) and by the absence of blastogenic response to concanavalin A (Difco Laboratories, Detroit, Mich.) or Escherichia coli lipopolysaccharide 055:B5 (Sigma Chemical Co., St. Louis, Mo.) in a standard blastogenesis assay (5, 9) .
Inoculation with C. albicans and treatment with poly(I. C).
In these experiments, the term acute systemic candidiasis means candidiasis following i.v. challenge with C. albicans. Mice were inoculated i.v. with 104 CFU of C. albicans in 0.1 ml of PBS. Control mice received 0.1 ml of PBS. For poly(I. C) treatment, mice were inoculated intraperitoneally (i.p.) with 100 ,ug (0.1 ml) of poly(I. C) (Sigma Chemical Co.) immediately prior to i.v. inoculation with C. albicans.
Control mice received 0.1 ml of PBS i.p.
The in vivo effect of poly(I. C) on splenic NK cell activity was determined in a standard 4-h 51Cr release assay with YAC-1 target cells as described previously (42) .
To determine the 50% lethal dose (LD50) of C. albicans for SCID mice, the mice (five mice per group) were inoculated i.v. with 104, 105, 106, or 107 CFU of C. albicans in 0.1 ml of saline. The LD50, based on the number of surviving mice in each group at 14 days after inoculation, was calculated by the Reed-Muench method (40) .
Treatment of C. albicans-monoassociated mice with poly(I. C). Mice were monoassociated with C. albicans by methods described previously (3, 10, 37) . Briefly, mice were orally inoculated with C. albicans by mixing C. albicans in the drinking water at a concentration of 105 CFU/ml. Thereafter, GF mice became colonized when they were transferred into flexible film isolators occupied by mice colonized with a pure culture of C. albicans. Mice are rapidly (within 24 h) colonized with C. albicans under these conditions (3, 10, 37) and remain chronically colonized with a pure culture of C. albicans. To assess the effect of poly(I. C) on candidiasis of endogenous origin, C. albicans-monoassociated mice were inoculated i.p. with poly(I. C) (100 ,ug) every other day for 6 days (a total of three inoculations) and killed 24 to 48 h after the third inoculation. The kidneys, spleen, liver, and brain were homogenized, diluted, and cultured to determine the number of CFU in poly(I C)-treated versus saline-treated control mice. Treatment with antibody. Rat monoclonal antibody (MAb) R4-6A2 (ATCC HB 170) to murine IFN--y was produced as ascites in pristane-primed BALB/c nude mice and purified by affinity chromatography. The protein concentration of the affinity-purified MAb was determined by the bicinchoninic acid protein assay (Pierce Chemicals, Rockford, Ill.). Enumeration of C. albicans. Internal organs were homogenized in 5 ml of PBS, aliquots were plated on SDA plates, and C. albicans CFU were counted after 24 h of incubation at 37°C. To determine the dry weight of organ homogenates, aliquots of homogenates were evaporated to dryness in aluminum weighing pans. The quantity of C. albicans recovered from internal organs is expressed as the log1o CFU ± the standard error of the mean (SEM) per gram (dry weight) of tissue.
Determination of candidacidal and phagocytic activity of M+. Thioglycollate (TG)-elicited peritoneal exudate cells were obtained by i.p. injection of 1 ml of sterile Brewer TG broth (3 g/100 ml; Difco) and lavage of the peritoneal cavity with RPMI 1640 medium 4 days later. To determine the effect of poly(I. C) treatment on the candidacidal activity of M+, mice were inoculated i.p. with 100 ,ug (100 ,ul) of poly(I * C) or 100 RI of sterile saline 24 h before collection of TG-elicited M+. After collection, TG-elicited peritoneal M4
(100 ,ul) were plated in triplicate in 96-well flat-bottomed microtiter plates (Falcon Microtest III; Becton Dickinson Labware, Lincoln Park, N.J.) at a density of 2 x 105 cells per well in RPMI 1640 containing 5% fetal bovine serum (low endotoxin; Sigma Chemical Co.). The candidacidal activity of M4 was assessed by previously published methods (13) . After 2 h of incubation at 37°C in a 5% CO2 incubator, nonadherent cells were removed by washing with RPMI 1640, and C. albicans (100 ,ul in RPMI 1640-5% fetal bovine serum) was added to give the indicated effector-to-target cell (E:T) ratio. After a further 4 h of incubation at 37°C, Triton X-100 was added to each well to give a final concentration of 0.1%, and the contents of each well were removed by vigorous pipetting and rinsing with distilled water. The contents of each well were then serially diluted in distilled water and plated on SDA plates for determination of CFU.
Control wells with C. albicans alone (no M+) were set up in parallel with the test wells. Percent killing was calculated as 100 -[(no. of CFU in test wells/no. of CFU in control wells) x 100]. Microscopic observation of the wells after rinsing with distilled water showed that removal of cells and yeasts was complete.
To determine M+ phagocytic activity, M4 were harvested from poly(I. C)-treated and saline-treated control mice as described above and plated (1 ml) in triplicate in eightchamber Lab-Tek slides (Nunc Inc., Naperville, Ill.) at a density of 106 cells per chamber. After 2 h of incubation at 37°C, nonadherent cells were removed by washing, and 2 x 106 CFU of C. albicans in 1 ml of RPMI 1640 was added. After 1 h of incubation at 37°C, slides were rinsed in PBS, fixed, stained (Diff-Quik stain; American Scientific Products, McGaw Park, Ill.), and scored for M+-associated C. albicans by microscopic examination. The phagocytic index was calculated as the number of C albicans associated with 100 M4 (26) .
The effect of poly(I. C) treatment on the phagocytic activity of M4 was also measured in an in vivo assay. To do this, M4 were elicited with TG as described above. Three days after inoculation with TG, mice were inoculated i.p. with 100 ,ug (100 ,u) of poly(I * C) or 100 pl of saline.
Twenty-four hours later, mice were inoculated i.p. with 5 x 107 CFU of C. albicans. One hour after i.p. inoculation with C. albicans, the peritoneal contents of poly(I. C)-treated and saline-treated control mice were collected by lavage, the peritoneal cells were adjusted to 5 x 105 cells per ml, 0.1 ml was spotted onto slides by cytospinning, and the slides were fixed and stained (Diff-Quik). Slides were scored for M+-associated C. albicans, and the phagocytic index was calculated as described above. The phagocytic activity of PMN SPLEEN LIVER 10 15 after inoculation KIDNEY Days after inoculation
Days after inoculation FIG. 1 . GF SCID and GF BALB/c mice were inoculated i.v. with 104 CFU of C. albicans. The gnotobiotic (i.e., C. albicans-infected, ex-GF) mice (six at each time point) were killed 1, 3, 7, and 14 days after inoculation, and the number of CFU in the liver, spleen, kidney, and brain was determined. Data are expressed as mean log10 CFU per gram (dry weight) SEM. Organs from which no viable C. albicans was recovered were assigned a value of 1. The SEM was not calculated when C. albicans was recovered from fewer than three of the six mice examined at any given time point. *, P < 0.05 compared with immunocompetent BALB/c mice.
was measured by the same method except that mice were inoculated i.p. with 5 x 107 C. albicans CFU 5 h after they were inoculated i.p. with TG.
To test the in vitro effect of poly(I. C) on the candidacidal activity of M+, TG-elicited MO were incubated with various concentrations (100, 10, and 0 ,ug/ml) of poly(I-C) for 24 h in vitro. Poly(I-C) was then removed by washing with RPMI 1640, C. albicans cells were added to give an E:T ratio of 10:1, and candidacidal activity was determined by enumeration of C albicans CFU as described above. Poly(I. C) did not affect the viability of M4) in these experiments, as determined by staining with 0.1% trypan blue. To test the in vitro effect of antibody to IFN on poly(I. C)-treated M4, anti-IFN was added concurrently with poly(I C). In these experiments, poly(I. C) was used at 100 ,ug/ml, anti-IFN-y was used at 17 ,ug/ml, anti-IFN-ax/ was used at 6,000 neutralizing units/ml, and anti-IFN-3 (rabbit anti-mouse IFN-13; Lee BioMolecular Research Laboratories, Inc., San Diego, Calif.) was used at 560 neutralizing units/ml. After incubation with anti-IFN and poly(I C) for 24 h, antibody and poly(I-C) were removed by washing with RPMI 1640, and M4 candidacidal activity was determined. Antibodies to IFN did not affect the viability of MX at the concentrations used, as determined by staining with 0.1% trypan blue.
Statistics. The Student t test was used to determine statistical significance between controls and treatment groups. P < 0.05 was considered significant.
RESULTS
Resistance of SCID mice to acute systemic candidiasis. Although SCID mice have no functional T-or B-cell responses (7), they are not more susceptible to acute systemic candidiasis than immunocompetent BALB/c mice (Fig. 1) . Following i.v. inoculation with 104 CFU, GF SCID mice not only cleared C. albicans from the spleen, kidney, and brain more rapidly than immunocompetent GF BALB/c mice, but they also cleared C. albicans from the liver by 14 days after inoculation ( Fig. 1) . At 14 days after inoculation, significantly fewer CFU per gram were recovered from the kidneys of SCID mice than from the kidneys of BALB/c mice. SCID mice with a bacterial flora of a gram-positive microorganism (flora defined) also showed resistance to acute systemic candidiasis (control data in Fig. 2 ). The LD50 of C. albicans in GF SCID mice following i.v. challenge was 6.13 x 105 CFU (data not shown).
Treatment with an IFN inducer enhances susceptibility of SCID mice to acute systemic candidiasis. To determine the in vivo effect of the IFN inducer poly(I C) on the susceptibility of SCID mice to acute systemic candidiasis, SCID mice were inoculated with poly(I. C) (100 ,ug, i.p.) and then challenged with C. albicans (10 CFU, i.v.). As shown in Organs from which C. albicans was not recovered were assigned a value of 1. The SEM was not calculated when C. albicans was recovered from fewer than three mice examined at a given time point. *, P < 0.05 compared with control C. albicans-infected mice. inoculation with C. albicans, 50-to 1,000-fold more CFU per gram were isolated from the livers, spleens, kidneys, and brains of poly(I. C)-treated mice than from control (salinetreated) mice (Fig. 2) .
Poly(I. C) treatment also enhanced the susceptibility of immunologically competent GF C57BL/6 (bgl+) mice to acute systemic candidiasis (data not shown). At 24 h after inoculation with poly(I * C) and i.v. challenge with C. albicans, poly(I. C)-treated bgl+ mice showed a 50-fold increase in the number of C. albicans recoverable from the kidneys and 3-to 4-fold increases in recoverable CFU in the liver and brain compared with saline-treated control mice (data not shown).
Treatment with an IFN inducer enhances susceptibility of SCID mice to systemic candidiasis of endogenous (intestinal tract) origin. Gnotobiotic SCID mice that were colonized (monoassociated) with a pure culture of C. albicans were not inherently susceptible to systemic candidiasis of endogenous origin, since several months of intestinal tract colonization with a pure culture of C. albicans did not result in systemic candidiasis (Table 1) . However, after poly(I-C) treatment, C. albicans was isolated from the livers, spleens, kidneys, and brains of monoassociated SCID mice, whereas C. albicans was not recovered from the livers, spleens, kidneys, or brains of any of six saline-treated control monoassociated SCID mice despite heavy colonization (107 to 108 viable CFU/g of cecal contents) of the intestinal tracts of these mice by a pure culture of C. albicans.
We also examined the effect of poly(I-C) on systemic candidiasis in bg/bg nulnu mice (Table 1) . Previously, our laboratory has demonstrated that this doubly immunodeficient mouse strain is inherently susceptible to systemic candidiasis of endogenous origin (10) but that systemic spread of C. albicans from the intestine and infection of internal organs do not occur until 8 to 16 weeks following monoassociation with C. albicans (10) . In poly(I. C)-treated bg/bg nulnu mice, however, systemic infection and significant colonization of the internal organs occurred within 7 days after monoassociation with C. albicans (Table 1) .
Consistent with previously reported results (10), salinetreated control bglbg nulnu mice had no or only low, sporadic numbers of C. albicans in the internal organs.
Antibodies to IFN-y and IFN-ot/0 abrogate poly(I-C)-enhanced susceptibility of SCID mice to systemic candidiasis. Poly(I-C) induces production of IFN--y by NK cells (18) and IFN-a and -,B by M4 (21, 22, 25, 30) in vivo. We used antibodies to the different types of IFN to determine whether poly(I. C)-enhanced susceptibility to systemic candidiasis albicans-infected mice; **, P < treated C. albicans-infected mici infected mice. Groups: 1, C. albi4 albicans; 3, anti-IFN-y plus poly IFN-a/P plus poly(I C) plus C.
IFN-al/, plus poly(I C) plus C. poly(I. C) plus C. albicans; 7, ant anti-asialo-GM1 plus anti-IFN-a/13
For these experiments, we inoculation with poly(I. C) and C. albicans challenge. The am mice treated with anti-IFN number of CFU per gram recovered from the kidneys of and C. albicans. The results poly(I . C)-and antibody-treated SCID mice (Fig. 3 , group 5) C)-enhanced susceptibility of at 24 h after inoculation with C. albicans was significantly :andidiasis could be abrogated lower than that recovered from poly(I. C)-treated mice (Fig. y plus anti-IFN-a/1 prior to 3, group 2) and comparable to that from control mice not treated with poly(I C) (Fig. 3, group 1) . Treatment with either anti-IFN--y (Fig. 3, group 3 ) or anti-IFN-a/1 (Fig. 3 , group 4) partially restored the resistance of poly(I. C)-treated mice to C. albicans, as evidenced by the intermediate numbers of CFU per gram recovered from the kidneys of these mice [significantly lower than that from poly(I. C)-treated mice without antibody (Fig. 3, group 2) but significantly higher than that from control mice (Fig. 3, group 1) ]. Antibody to IFN-aL/j (Fig. 3, group 4 ) was more effective than MLAb to IFN--y (Fig. 3, group 3 ) in restoring the resistance of poly(I. C)-treated mice to candidiasis. We further examined the effect of antibody to IFN in mice depleted of NK cell activity (Fig. 3) . Treatment with antiasialo-GM1 prior to inoculation with poly(I-C) and C. albicans did not significantly alter the poly(I. C)-enhanced susceptibility of SCID mice to C. albicans, as evidenced by an insignificant reduction in CFU per gram in the kidneys of anti-asialo-GM1-and poly(I-C)-treated mice (Fig. 3 , group 6) compared with that in poly(I. C)-treated mice not treated with anti-asialo-GM1 (Fig. 3, group 2) . However, when anti-asialo-treated mice were administered anti-IFN-citI prior to inoculation with poly(I-C) and C. albicans, the effect of poly(I. C) was negated, as shown by the comparable numbers of CFU per gram recovered from the kidneys of 47 8 these mice (Fig. 3, group 8 ) and control mice (Fig. 3 , group gated by treatment with anti-IFN-al1 alone (Fig. 3, group 8 ).
compared with poly(I. C)-
In these experiments, the in vivo neutralizing efficacy of e and with control C albicansMAb to IFN and depletion of NK cell activity by anti-asialocans alone; 2, poly(I* C) plus C. GM1 were monitored by splenic NK cell activity (Fig. 4). adbicaCs; 5, anti-IFN-l plus anti-Poly(I. C) treatment of SCID mice (Fig. 4, group 2) signifalbicans; 6, anti-asialo-GM1 plus icantly enhanced NK cell activity over levels found in ti-asialo-GM1 plus C. albicans; 8, control mice (Fig. 4, group 1 Fig. 3 .
cantly reduced NK cell activity to minimal levels in both control (Fig. 4, group 7) and poly(I. C)-treated (Fig. 4,  group 6 ) mice. Treatment with antibody to both IFN-,y and IFN-a/, in poly(I C)-treated mice (Fig. 4, group 5 ) reduced NK cell activity to the levels found in control mice. Antibody to either IFN-y (Fig. 4, group 3 ) or IFN-a/I (Fig. 4 , group 4) did not reduce NK cell activity in poly(I. C)-treated mice to the levels seen in control mice.
Poly(I. C) impairs the phagocytic and candidacidal activity of M+ from SCID mice. The effect of poly(I. C) on the candidacidal activity of M4 from SCID mice was examined (Table 2) . TG-elicited peritoneal M4 from poly(I-C)-treated SCID mice showed significantly reduced candidacidal activity compared with TG-elicited peritoneal M4 from salinetreated control mice. Incubation of C. albicans with M4 from poly(I. C)-treated mice resulted in 55 and 66% killing of C. albicans at E:T ratios of 10:1 and 100:1, respectively. Incubation of C. albicans with control M( resulted in 71% (E:T, 10:1) and 88% (E:T, 100:1) killing of C. albicans.
We also compared the capacity of Mi from poly(I-C)-treated and saline-treated control SCID mice to phagocytize C. albicans ( Table 2 ). The phagocytic index (mean number of C. albicans associated with 100 MO) for M+ from poly(I. C)-treated mice was 225, compared with 463 for M4 from saline-treated control mice. In addition, germ tube formation by M4-associated C. albicans was higher (27.3%) with M4 from poly(I. C)-treated mice than with M4-associated C. albicans in cultures from saline-treated control mice (mean, 7.1%). Similar inhibitory effects of poly(I. C) were found with an in vivo assay that measured the phago- In vitro treatment with poly(I. C) also reduced the candidacidal activity of TG-elicited M+ from SCID mice. Following incubation with poly(I-C) (100 lO g/ml) for 24 h in vitro, the mean candidacidal activity of M4 was reduced from 35.3 to 2.5% at an E:T ratio of 10:1. A significant reduction in M4 candidacidal activity (from 35.3 to 23%) was also seen when poly(I-C) was used at 10 p,g/ml (E:T, 10:1). We next investigated whether antibody to IFN affected poly(I C)-induced suppression of candidacidal activity of M4 in vitro. Poly(I. C)-induced suppression of candidacidal activity of M4 in vitro was reversed by treatment with anti-IFN-a/3, anti-IFN-1, and a mixture of anti-IFN-cL/13 plus anti-IFN-y, but not by anti-IFN--y alone (Table 3 ). Higher concentrations of IFN--y (up to 51 ,ug/ml) did not reverse poly(I. C)-induced suppression of candidacidal activity of M4 (data not shown). The congenitally immunodeficient SCID mouse, which lacks functional T and B cells (7) , is an excellent animal Poly(I * C) (100 pg/ml) 5 .0 ± 5.15b Poly(I C) + anti-IFN-y (17 ,ug/ml) 4.5 3.91b Poly(I C) + anti-IFN-a/ (6,000 U/ml) 21 (29, 34) and suggests that innate immunity plays an important role in host resistance to systemic candidiasis.
In these experiments, we used the IEN inducer poly(I. C) to study the immunomodulatory role of in vivo-induced IFNs on innate immunity to C. albicans in SCID mice. In vivo induction of IFN by poly(I-C) markedly enhanced the susceptibility of SCID mice to acute systemic candidiasis, as shown by the impaired capacity of poly(I * C)-treated SCID mice to clear C. albicans from the internal organs following i.v. challenge. The impaired capacity of poly(IT C)-treated SCID mice to clear C. albicans was evident in the four internal organs (liver, spleen, kidney, and brain) we examined, although the effect was most pronounced in the kidney. While poly(I C)-treated SCID mice had significantly more C. albicans in the internal organs for 7 days after i.v. challenge, it is not known whether this is due to impairment of innate immune cell functions over this entire time period or merely reflects an initial replicative advantage for C. albicans in the poly(IT C)-treated SCID mouse. Typically, the effect of poly(I-C) (IFN production) on NK cells (18) and M4 (30) is most pronounced at 24 h after treatment. We also observed that poly(I -C) treatment enhanced the susceptibility of immunocompetent C57BV-6 mice to systemic candidiasis. The poly(IT C)-enhanced susceptibility of GF C57BL/6 mice to acute systemic candidiasis at 24 h after treatment, before the expected onset of an acquired immune response in these immunologically naive mice, is consistent with the hypothesis that poly(I. C) affects innate immune cell function. The increased susceptibility of SCID mice and C57BL16 mice to acute systemic candidiasis following treatment with poly(I -C) suggests that IFNs act to impair the anti-C. albicans activity of phagocytic cells in vivo. A previous study also suggested that poly(I-C) increases the susceptibility of mice to acute systemic candidiasis, although no mechanism was proposed (44) .
In vivo, poly(IT C) induces the production of all three classes of IFN by cells important in innate immunity (18, 21, 22, 25, 30) . The data in this study show that IFN production induced by poly(I-C) enhanced the susceptibility of SCID mice to systemic candidiasis. In our experiments, neutralization of both IFN-y and IFN-a/0 was needed to abrogate poly(IT C)-enhanced susceptibility to acute systemic candidiasis in SCID mice. When used individually, antibodies to either IFN-y or IFN-a/l only partially restored the innate resistance of SCID mice to acute systemic candidiasis, although treatment with anti-IFN-a/$ was more effective than treatment with anti-IEN-y in restoring resistance. A previous in vivo (23) study with conventional immunocompetent BALB/c mice suggested that IFN-y increased murine susceptibility to acute systemic candidiasis prior to the onset of an acquired immune response but had the opposite effect in mice with a demonstrable acquired immune response to C albicans (23) . Our data for SCID mice, which cannot mount an acquired immune response to C. albicans, demonstrate not only that IFN--y impairs innate host immunity to C. albicans but also that IFN-a/3 has the same (and possibly a more significant) effect in vivo. Our data further suggest that both IFN-y and IFN-a/1 can enhance the susceptibility of SCID mice to C. albicans, possibly through similar or compensatory mechanisms. production of IFN-a/1 by M+ (21, 22, 30) , and in mice the primary effect of poly(IT C) has been shown to be the induction of IFN-3 by M+ (25) .
The results of this study are consistent with an effect of poly(I-C) on the M+. In humans, monokines from IFNstimulated M4 have been shown to affect PMN function (17) . Our (26) and that IFN-al,B may act as an inhibitor of CSF-1-induced monocytopoiesis (31) . CSF-1 is produced in vivo in response to systemic infection with C. albicans (13) . Conceivably, at least part of the effect of poly(I. C)-induced IFN-a/13 in SCID mice observed in these experiments may be due to the antagonistic effect of IFN-aL1 on CSF-1 activity. Highly activated M4 show reduced levels of mannose-binding receptors (24) . Thus, the IFN--y produced by NK cells in poly(I. C)-treated SCID mice could also be acting on the Mi to diminish their capacity to phagocytize C. albicans.
Previously, work in our laboratory has demonstrated that systemic spread of C. albicans from the intestine and infection of internal organs occur in mice that are deficient in both innate and T-cell immune functions (10) and that both immunodeficiencies appear to be necessary for systemic spread of C. albicans from the intestines of monoassociated mice. In the present study, impairment of innate immunity in C. albicans-colonized (pure culture) SCID mice by poly(I. C) resulted in infection of the internal organs with C. albicans, whereas untreated monoassociated SCID mice were resistant to systemic infection. These results support our previous conclusion (10) that impairment of both innate and T-cell immune functions is necessary for systemic spread of C. albicans from the intestine and in addition suggest that impairment of M4 function in T-and B-celldeficient SCID mice allows intestinal C. albicans to invade internal organs.
An interesting observation made in this study was that SCID mice depleted of NK cell activity by anti-asialo-GM1 were not more susceptible to acute systemic candidiasis than were SCID mice with normal NK cell activity. This suggests that NK cells do not play an important role in innate resistance to systemic candidiasis in SCID mice. Other investigators have also suggested that NK cells do not play a role in resistance to candidiasis (1, 2, 45) , although IFN-y from NK cells can enhance the candidacidal activity of human PMN in vitro (17) .
